Stallergenes Greer at a glance
Stallergenes Greer is a fully integrated global biopharmaceutical company
Stallergenes Greer is a global healthcare company specialising in the diagnosis and treatment of allergies through the development and commercialisation of allergy immunotherapy (AIT) products and services.
Our purpose:
Enabling precision medicine to improve life for people with allergies
Our ambition:
Becoming the world's eading allergen immunotherapy company
The combination of Stallergenes SA and Greer Laboratories, Inc. has led to the creation of ONE Stallergenes Greer – a company with the largest finished AIT product manufacturing globally, an extensive global footprint and a product portfolio which offers solutions across the immunotherapy value chain.
2019 Company report
Click here to view 2019 Annual Report